The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yamauchi, Hajime ^a   Matsumaru, Takanori ^a   Morita, Tomoko ^a   Ishikawa, Susumu ^a   Maenaka, Katsumi ^a   Takigawa, Ichigaku ^a   Semba, Kentaro ^b,c   Kon, Shunsuke ^a   Fujita, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAZOLE DERIVATIVE; MOLECULAR LIBRARY; REBECCAMYCIN;

ANIMAL; CELL COMMUNICATION; CELL DEATH; CELL SURVIVAL; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; EPITHELIUM CELL; GENETICS; HIGH THROUGHPUT SCREENING; INTESTINE MUCOSA; METABOLISM; MOLECULAR LIBRARY; ONCOGENE RAS; TRANSFORMED CELL LINE; TUMOR CELL LINE;

ANIMALS; CARBAZOLES; CELL COMMUNICATION; CELL DEATH; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL CELLS; GENES, RAS; HIGH-THROUGHPUT SCREENING ASSAYS; INTESTINAL MUCOSA; SMALL MOLECULE LIBRARIES;

EID: 84944789880     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15336     Document Type: Article

References (28)

1. Amoyel, M., & Bach, E. A. Cell competition: how to eliminate your neighbours. Development. 141, 988-1000 (2014
2. Baker, N. E. Cell competition. Curr Biol. 21, R11-15 (2011
3. Vincent, J. P., Fletcher, A. G., & Baena-Lopez, L. A. Mechanisms and mechanics of cell competition in epithelia. Nat Rev Mol Cell Biol. 14, 581-591 (2013
4. Johnston, L. A. Competitive interactions between cells: death, growth, and geography. Science. 324, 1679-1682 (2009
5. Levayer, R., & Moreno, E. Mechanisms of cell competition: themes and variations. J Cell Biol. 200, 689-698 (2013
6. Fujita, Y. Interface between normal and transformed epithelial cells-A road to a novel type of cancer prevention and treatment. Cancer Sci (2011
7. Hogan, C., Kajita, M., Lawrenson, K., & Fujita, Y. Interactions between normal and transformed epithelial cells: Their contributions to tumourigenesis. Int J Biochem Cell Biol. 43, 496-503 (2011
8. Leung, C. T., & Brugge, J. S. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature. 482, 410-413 (2012
9. Wu, S. K., et al. Cortical F-Actin stabilization generates apical-lateral patterns of junctional contractility that integrate cells into epithelia. Nat Cell Biol. 16, 167-178 (2014
10. Hogan, C., et al. Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol. 11, 460-467 (2009
11. Kajita, M., et al. Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Srctransformed cells. J Cell Sci. 123, 171-180 (2010
12. Tamori, Y., et al. Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol. 8, e1000422, doi: 10.1371/journal. pbio.1000422 (2010
13. Norman, M., et al. Loss of Scribble causes cell competition in mammalian cells. J Cell Sci. 125, 59-66 (2012
14. Kajita, M., et al. Filamin acts as a key regulator in epithelial defence against transformed cells. Nature communications. 5, 4428, doi: 10.1038/ncomms5428 (2014
15. Simons, K., & Fuller, S. D. Cell surface polarity in epithelia. Annual review of cell biology. 1, 243-288 (1985
16. Karnoub, A. E., & Weinberg, R. A. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 9, 517-531 (2008
17. Bailly, C., et al. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue. Molecular pharmacology. 55, 377-385 (1999
18. Bush, J. A., Long, B. H., Catino, J. J., Bradner, W. T., & Tomita, K. Production and biological activity of rebeccamycin, a novel antitumor agent. The Journal of antibiotics. 40, 668-678 (1987
19. Ohoka, A., et al. EPLIN is a crucial regulator for extrusion of RasV12-Transformed cells. J Cell Sci. 128, 781-789 (2015
20. Sato, T., et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 459, 262-265 (2009
21. Hussain, M., et al. A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer. Investigational new drugs. 21, 465-471 (2003
22. Goel, S., et al. A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer. Investigational new drugs. 21, 103-107 (2003
23. Dowlati, A., et al. Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer. Investigational new drugs. 23, 563-567 (2005
24. Schwandt, A., et al. Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 7, 751-754 (2012
25. Anton, K. A., et al. PKA-regulated VASP phosphorylation promotes extrusion of transformed cells from the epithelium. J Cell Sci. 127, 3425-3433 (2014
26. Merino, M. M., et al. Elimination of unfit cells maintains tissue health and prolongs lifespan. Cell. 160, 461-476 (2015
27. Doi, A., et al. Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-To-mesenchymal transition and disruption of mammary acinar structures. Molecular oncology. 9, 355-364 (2015
28. Hogan, C., et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol Cell Biol. 24, 6690-6700 (2004